Darcy Mootz
Direktor/Vorstandsmitglied bei ELEVATION ONCOLOGY, INC.
Vermögen: - $ am 30.04.2024
Profil
Darcy Mootz is an Independent Director at Elevation Oncology, Inc. They previously worked as a Senior Director-Corporate Development at Achaogen, Inc. and as a Chief Business Officer at Oric Pharmaceuticals, Inc. Dr. Mootz completed their undergraduate degree at Duke University and their doctorate degree at Harvard University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ELEVATION ONCOLOGY, INC.
-.--% | 31.03.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Darcy Mootz
| Unternehmen | Position | Beginn |
|---|---|---|
| ELEVATION ONCOLOGY, INC. | Direktor/Vorstandsmitglied | 18.01.2024 |
Ehemalige bekannte Positionen von Darcy Mootz
| Unternehmen | Position | Ende |
|---|---|---|
| ORIC PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Alpha-9 Oncology, Inc.
 Alpha-9 Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Alpha-9 Theranostics, Inc. operates as a clinical stage radiopharmaceutical company. It engages in developing breakthrough targeting agents for cancer imaging by positron emission tomography (PET) and therapy using targeted radioisotopes. The company was founded by Fran?ois B?nard, David Perrin, Kuo-Shyan Lin, and Ian McBeath and is headquartered in Vancouver, Canada. | Direktor/Vorstandsmitglied | - |
| ACHAOGEN | Corporate Officer/Principal | - |
Ausbildung von Darcy Mootz
| Harvard University | Doctorate Degree |
| Duke University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ORIC PHARMACEUTICALS, INC. | Health Technology |
| ELEVATION ONCOLOGY, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
Alpha-9 Oncology, Inc.
Alpha-9 Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Alpha-9 Theranostics, Inc. operates as a clinical stage radiopharmaceutical company. It engages in developing breakthrough targeting agents for cancer imaging by positron emission tomography (PET) and therapy using targeted radioisotopes. The company was founded by Fran?ois B?nard, David Perrin, Kuo-Shyan Lin, and Ian McBeath and is headquartered in Vancouver, Canada. | Commercial Services |